Preliminary falsification of EIA screening is cost-effective in the two-step serodiagnosis of lyme disease.
Piras
M A
MA
Aceti
A
A
D015153:Blotting, Western; D003362:Cost-Benefit Analysis; D006801:Humans; D007124:Immunoenzyme Techniques; D008193:Lyme Disease / Q000175:diagnosis*; D008403:Mass Screening; D012680:Sensitivity and Specificity; D012698:Serologic Tests / Q000191:economics